Related references
Note: Only part of the references are listed.Mortality in Patients with Bullous Pemphigoid: A Retrospective Cohort Study, Systematic Review and Meta-analysis
Khalaf Kridin et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Cancer is not a risk factor for bullous pemphigoid: 10-year population-based cohort study
C. T. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Mortality and risk factors among Israeli bullous pemphigoid patients
Mati Rozenblat et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2019)
Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up
Agnieszka Kalinska-Bienias et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2019)
Smoking, but not alcohol, is associated with risk of psoriasis in a Taiwanese population-based cohort study
Ying-Xiu Dai et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
Hywel C. Williams et al.
LANCET (2017)
An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone
M. Sticherling et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment
Philippe Bernard et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
C. Feliciani et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Non- antibiotic properties of tetracyclines and their clinical application in dermatology
Leanna J. Perret et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2014)
Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly
Chen-Yi Wu et al.
PLOS ONE (2014)
Incidence and Mortality of Bullous Pemphigoid in France
Pascal Joly et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan
Ching-Lan Cheng et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders
Jennifer L. Akerblom et al.
AGE AND AGEING (2008)
A retrospective analysis of patients with bullous pemphigoid treated with methotrexate
Petra Kjellman et al.
ARCHIVES OF DERMATOLOGY (2008)
Mortality of bullous pemphigoid: An evaluation of 223 patients and comparison with the mortality in the general population in the United States
Sareeta R. S. Parker et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid
Stefan Beissert et al.
ARCHIVES OF DERMATOLOGY (2007)
Neurological disorders in patients with bullous pemphigoid
Nadege Cordel et al.
DERMATOLOGY (2007)
Side effects of corticosteroid therapy
AL Buchman
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)